These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 30665568)

  • 1. Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Floege J; Barbour SJ; Cattran DC; Hogan JJ; Nachman PH; Tang SCW; Wetzels JFM; Cheung M; Wheeler DC; Winkelmayer WC; Rovin BH;
    Kidney Int; 2019 Feb; 95(2):268-280. PubMed ID: 30665568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Rovin BH; Caster DJ; Cattran DC; Gibson KL; Hogan JJ; Moeller MJ; Roccatello D; Cheung M; Wheeler DC; Winkelmayer WC; Floege J;
    Kidney Int; 2019 Feb; 95(2):281-295. PubMed ID: 30665569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological spectrum of glomerular disease in patients with renal insufficiency: a single-center study in Northeastern China.
    Chen L; Luodelete M; Dong C; Li B; Zhang W; Nie P; Liu J; Chen X; Luo P
    Ren Fail; 2019 Nov; 41(1):473-480. PubMed ID: 31198075
    [No Abstract]   [Full Text] [Related]  

  • 4. CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.
    Mariani LH; Bomback AS; Canetta PA; Flessner MF; Helmuth M; Hladunewich MA; Hogan JJ; Kiryluk K; Nachman PH; Nast CC; Rheault MN; Rizk DV; Trachtman H; Wenderfer SE; Bowers C; Hill-Callahan P; Marasa M; Poulton CJ; Revell A; Vento S; Barisoni L; Cattran D; D'Agati V; Jennette JC; Klein JB; Laurin LP; Twombley K; Falk RJ; Gharavi AG; Gillespie BW; Gipson DS; Greenbaum LA; Holzman LB; Kretzler M; Robinson B; Smoyer WE; Guay-Woodford LM;
    Am J Kidney Dis; 2019 Feb; 73(2):218-229. PubMed ID: 30420158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases.
    Rovin BH; Adler SG; Barratt J; Bridoux F; Burdge KA; Chan TM; Cook HT; Fervenza FC; Gibson KL; Glassock RJ; Jayne DRW; Jha V; Liew A; Liu ZH; Mejía-Vilet JM; Nester CM; Radhakrishnan J; Rave EM; Reich HN; Ronco P; Sanders JF; Sethi S; Suzuki Y; Tang SCW; Tesar V; Vivarelli M; Wetzels JFM; Lytvyn L; Craig JC; Tunnicliffe DJ; Howell M; Tonelli MA; Cheung M; Earley A; Floege J
    Kidney Int; 2021 Oct; 100(4):753-779. PubMed ID: 34556300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Risk of Cardiovascular Events in Individuals With Primary Glomerular Diseases.
    Canney M; Gunning HM; Zheng Y; Rose C; Jauhal A; Hur SA; Sahota A; Reich HN; Barbour SJ
    Am J Kidney Dis; 2022 Dec; 80(6):740-750. PubMed ID: 35659570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
    Bazzi C; Rizza V; Casellato D; Stivali G; Rachele G; Napodano P; Olivieri G; Gallieni M; D'Amico G
    J Nephrol; 2012; 25(5):810-8. PubMed ID: 22252844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal and Demographic Trends in Glomerular Disease Epidemiology in the Southeastern United States, 1986-2015.
    O'Shaughnessy MM; Hogan SL; Poulton CJ; Falk RJ; Singh HK; Nickeleit V; Jennette JC
    Clin J Am Soc Nephrol; 2017 Apr; 12(4):614-623. PubMed ID: 28325866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary and secondary glomerular diseases].
    Birck R; Banas B
    Dtsch Med Wochenschr; 2011 Apr; 136(14):703-5. PubMed ID: 21448831
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Eckardt KU; Bansal N; Coresh J; Evans M; Grams ME; Herzog CA; James MT; Heerspink HJL; Pollock CA; Stevens PE; Tamura MK; Tonelli MA; Wheeler DC; Winkelmayer WC; Cheung M; Hemmelgarn BR;
    Kidney Int; 2018 Jun; 93(6):1281-1292. PubMed ID: 29656903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canadian Society of Nephrology commentary on the KDIGO clinical practice guideline for CKD evaluation and management.
    Akbari A; Clase CM; Acott P; Battistella M; Bello A; Feltmate P; Grill A; Karsanji M; Komenda P; Madore F; Manns BJ; Mahdavi S; Mustafa RA; Smyth A; Welcher ES
    Am J Kidney Dis; 2015 Feb; 65(2):177-205. PubMed ID: 25511161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.
    Inker LA; Astor BC; Fox CH; Isakova T; Lash JP; Peralta CA; Kurella Tamura M; Feldman HI
    Am J Kidney Dis; 2014 May; 63(5):713-35. PubMed ID: 24647050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overlapping syndrome of IgA nephropathy and lipoid nephrosis.
    Lai KN; Lai FM; Chan KW; Ho CP; Leung AC; Vallance-Owen J
    Am J Clin Pathol; 1986 Dec; 86(6):716-23. PubMed ID: 3538845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New diagnostic tests and new therapies for glomerular diseases.
    Appel GB; Appel AS
    Blood Purif; 2013; 35(1-3):81-5. PubMed ID: 23343551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistent findings of renal glomerular disease with Hashimoto's thyroiditis.
    Koçak G; Huddam B; Azak A; Ortabozkoyun L; Duranay M
    Clin Endocrinol (Oxf); 2012 May; 76(5):759-62. PubMed ID: 22106873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The pathology of glomerulonephritis].
    Thoenes W
    Internist (Berl); 1989 Mar; 30(3):127-39. PubMed ID: 2654057
    [No Abstract]   [Full Text] [Related]  

  • 17. Outcomes of normotensive IgA nephropathy patients with mild proteinuria who have impaired renal function.
    Tan M; Fang J; Xu Q; Zhang C; Zou G; Wang M; Li W
    Ren Fail; 2019 Nov; 41(1):875-882. PubMed ID: 31517550
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of nuclear factor-kappaB in IgA nephropathy using Southwestern histochemistry.
    Ashizawa M; Miyazaki M; Abe K; Furusu A; Isomoto H; Harada T; Ozono Y; Sakai H; Koji T; Kohno S
    Am J Kidney Dis; 2003 Jul; 42(1):76-86. PubMed ID: 12830459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low glomerular density with glomerulomegaly in obesity-related glomerulopathy.
    Tsuboi N; Utsunomiya Y; Kanzaki G; Koike K; Ikegami M; Kawamura T; Hosoya T
    Clin J Am Soc Nephrol; 2012 May; 7(5):735-41. PubMed ID: 22403274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid therapy in children with IgA nephropathy.
    Cambier A; Boyer O; Deschenes G; Gleeson J; Couderc A; Hogan J; Robert T
    Pediatr Nephrol; 2020 Mar; 35(3):359-366. PubMed ID: 30778826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.